TAP-independent antigen presentation on MHC class I molecules: Lessons from Epstein-Barr virus

Microbes and Infection

Volumn 5, Issue 4, 2003, Pages 291-299

  Lautscham, Georg ^a   Rickinson, Alan ^b   Blake, Neil ^c  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Epstein Barr virus (EBV); Hydrophobicity; MHC class I processing; TAP independence

Indexed keywords

CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN PRESENTATION; CELL SURFACE; CYTOSOL; ENDOPLASMIC RETICULUM; EPSTEIN BARR VIRUS; LYMPHOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVIEW;

HUMAN HERPESVIRUS 4;

EID: 0037386520     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(03)00031-5     Document Type: Review

References (50)

1. Pamer E., Cresswell P. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16:1998;323-358.
2. Williams A., Peh C.A., Elliott T. The cell biology of MHC class I antigen presentation. Tissue Antigens. 59:2002;3-17.
3. Kessler B., Glas R., Ploegh H.L. MHC class I antigen processing regulated by cytosolic proteolysis - short cuts that alter peptide generation. Mol. Immunol. 39:2002;171-179.
4. Mosse C.A., Meadows L., Luckey C.J., Kittlesen D.J., Huczko E.L., Slingluff C.L., Shabanowitz J., Hunt D.F., Engelhard V.H. The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol. J. Exp. M. 187:1998;37-48.
5. Henderson R.A., Michel H., Sakaguchi K., Shabanowitz J., Appella E., Hunt D.F., Engelhard V.H. HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science. 255:1992;1264-1266.
6. Wei M.L., Cresswell P. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature. 356:1992;443-446.
7. Huczko E.L., Bodnar W.M., Benjamin D., Sakaguchi K., Zhu N.Z., Shabanowitz J., Henderson R.A., Appella E., Hunt D.F., Engelhard V.H. Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling. J. Immunol. 151:1993;2572-2587.
8. Henderson R.A., Cox A.L., Sakagughi K., Appella E., Shabanowitz J., Hunt D.F., Engelhard V.H. Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells. Proc. Natl. Acad. Sci. USA. 90:1993;10275-10279.
9. Gueguen M., Biddison W.E., Long E.O. T cell recognition of an HLA-A2-restricted epitope derived from a cleaved signal sequence. J. Exp. M. 180:1994;1989-1994.
10. Wolfel C., Drexler I., Van Pel A., Thres T., Leister N., Herr W., Sutter G., Huber G., Wolfel T. Transporter (TAP)- and proteasome-independent presentation of a melanoma-associated tyrosinase epitope. Int. J. Cancer. 88:2000;432-438.
11. Hombach J., Pircher H., Tonegawa S., Zinkernagel R.M. Strictly transporter of antigen presentation (TAP)-dependent presentation of an immunodominant cytotoxic T lymphocyte epitope in the signal sequence of a virus protein. J. Exp. M. 182:1995;1615-1619.
12. Braud V.M., Allan D.S.J., Wilson D., McMichael A.J. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr. Biol. 8:1997;1-10.
13. Hammond S.A., Johnson R.P., Kalams S.A., Walker B.D., Takiguchi M., Safrit J.T., Koup R.A., Siliciano R.F. An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8+ CTL. J. Immunol. 154:1995;6140-6156.
14. Gil-Torregrosa B.C., Raul Castano A., Del Val M. Major histocompatibility complex class I viral antigen processing in the secretory pathway defined by the trans-Golgi network protease furin. J. Exp. M. 188:1998;1105-1116.
15. Carbonetti N.H., Irish T.J., Chen C.H., O'Connell C.B., Hadley G.A., McNamara U., Tuskan R.G., Lewis G.K. Intracellular delivery of a cytotoxic T-lymphocyte epitope peptide by pertussis toxin to major histocompatibility complex class I without involvement of the cytosolic class I antigen processing pathway. Infect. Immun. 67:1999;602-607.
16. Lu J., Wettstein P.J., Higashimoto Y., Appella E., Celis E. TAP-independent presentation of CTL epitopes by trojan antigens. J. Immunol. 166:2001;7063-7071.
17. Snyder H.L., Bacik I., Bennink J.R., Kearns G.T., Behrens T.W., Bachi T., Orlowski M., Yewdell J.W. Two novel routes of transporter associated with antigen processing (TAP)-independent major histocompatibility complex class I antigen processing. J. Exp. M. 186:1997;1087-1098.
18. Steven N.M., Annels N.E., Kumar A., Leese A.M., Kurilla M.G., Rickinson A.B. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J. Exp. M. 185:1997;1605-1617.
19. Longnecker R. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence? Adv. Cancer Res. 79:2000;175-200.
20. Lee S.P., Thomas W.A., Blake N.W., Rickinson A.B. Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2. Eur. J. Immunol. 26:1996;1875-1883.
21. Khanna R., Burrows S.R., Moss D.J., Silins S.L. Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies. J. Virol. 70:1996;5357-5362.
22. de la Salle H., Houssaint E., Peyrat M.A., Arnold D., Salamero J., Pinczon D., Stevanovic S., Bausinger H., Fricker D., Gomard E., Biddison W., Lehner P., UytdeHaag F., Sasportes M., Donato L., Rammensee H.G., Cazenave J.P., Hanau D., Tongio M.M., Bonneville M. Human peptide transporter deficiency: importance of HLA-B in the presentation of TAP-independent EBV antigens. J. Immunol. 158:1997;4555-4563.
23. Lautscham G., Mayrhofer S., Taylor G., Haigh T., Leese A., Rickinson A., Blake N. Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway. J. Exp. M. 194:2001;1053-1068.
24. Lautscham G., Haigh T., Mayrhofer S., Taylor G., Croom-Carter D., Leese A., Gadola S., Cerundolo V., Rickinson A., Blake N. Identification of a TAP-independent, immunoproteasome-dependent CD8+ T cell epitope in Epstein-Barr virus latent membrane protein 2. J. Virol. 77:2003;2757-2761.
25. Norbury C.C., Princiotta M.F., Bacik I., Brutkiewicz R.R., Wood P., Elliott T., Bennink J.R., Yewdell J.W. Multiple antigen-specific processing pathways for activating naive CD8+ T cells in vivo. J. Immunol. 166:2001;4355-4362.
26. Wiertz E.J., Tortorella D., Bogyo M., Yu J., Mothes W., Jones T.R., Rapoport T.A., Ploegh H.L. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature. 384:1996;432-438.
27. Koopmann J.O., Albring J., Huter E., Bulbuc N., Spee P., Neefjes J., Hammerling G.J., Momburg F. Export of antigenic peptides from the endoplasmic reticulum intersects with retrograde protein translocation through the Sec61p channel. Immunity. 13:2000;117-127.
28. Koppelman B., Zimmerman D.L., Walter P., Brodsky F.M. Evidence for peptide transport across microsomal membranes. Proc. Natl. Acad. Sci. USA. 89:1992;3908-3912.
29. Saulquin X., Bodinier M., Peyrat M.A., Hislop A., Scotet E., Lang F., Bonneville M., Houssaint E. Frequent recognition of BCRF1, a late lytic cycle protein of Epstein-Barr virus, in the HLA-B*2705 context: evidence for a TAP-independent processing. Eur. J. Immunol. 31:2001;708-715.
30. Sigal L.J., Crotty S., Andino R., Rock K.L. Cytotoxic T cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature. 398:1999;77-80.
31. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245-252.
32. Levitskaya J., Coram M., Levitsky V., Imreh S., Steigerwald-Mullen P.M., Klein G., Kurilla M.G., Masucci M.G. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature. 375:1995;685-688.
33. Blake N., Lee S., Redchenko I., Thomas W., Steven N., Leese A., Steigerwald-Mullen P., Kurilla M.G., Frappier L., Rickinson A. Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. Immunity. 7:1997;791-802.
34. Blake N., Haigh T., Shaka'a G., Croom-Carter D., Rickinson A. The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1. J. Immunol. 165:2000;7078-7087.
35. Kovacsovics-Bankowski M., Rock K.L. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science. 267:1995;243-246.
36. Norbury C.C., Chambers B.J., Prescott A.R., Ljunggren H.G., Watts C. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur. J. Immunol. 27:1997;280-288.
37. Norbury C.C., Hewlett L.J., Prescott A., Shastri N., Watts C. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity. 3:1995;783-791.
38. Stober D., Trobonjaca Z., Reimann J., Schirmbeck R. Dendritic cells pulsed with exogenous hepatitis B surface antigen particles efficiently present epitopes to MHC class I-restricted cytotoxic T cells. Eur. J. Immunol. 32:2002;1099-1108.
39. Liu T., Zhou A., Overall C., Lederer E., Ljunggren H.G., Jondal M. Heat-inactivated Sendai virus can enter multiple MHC class I processing pathways and generate cytotoxic T lymphocyte responses in vivo. J. Immunol. 154:1995;3147-3155.
40. Pfeifer J.D., Wick M.J., Roberts R.L., Findlay K., Normark S.J., Harding C.V. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature. 361:1993;359-362.
41. Bachmann M.F., Oxenius A., Pircher H., Hengartner H., Ashton-Richardt P.A., Tonegawa S., Zinkernagel R. TAP1-independent loading of class I molecules by exogenous viral proteins. Eur. J. Immunol. 25:1995;1739-1743.
42. Schirmbeck R., Melber K., Reimann J. Hepatitus B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatability complex class I-restricted epitope presentation. Eur. J. Immunol. 25:1995;1063-1070.
43. Gromme M., Uytdehaag F.G., Janssen H., Calafat J., van Binnendijk R.S., Kenter M.J., Tulp A., Verwoerd D., Neefjes J. Recycling MHC class I molecules and endosomal peptide loading. Proc. Natl. Acad. Sci. USA. 96:1999;10326-10331.
44. - dendritic cells: a dispensable role for TAP. Eur. J. Immunol. 32:2002;818-825.
45. Keating S., Prince S., Jones M., Rowe M. The lytic cycle of Epstein-Barr virus is associated with decreased expression of cell surface major histocompatibility complex class I and class II molecules. J. Virol. 76:2002;8179-8188.
46. Tortorella D., Gewurz B.E., Furman M.H., Schust D.J., Ploegh H.L. Viral subversion of the immune system. Annu. Rev. Immunol. 18:2000;861-926.
47. Zeidler R., Eissner G., Meissner P., Uebel S., Tampe R., Lazis S., Hammerschmidt W. Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10. Blood. 90:1997;2390-2397.
48. Gadola S.D., Moins-Teisserenc H.T., Trowsdale J., Gross W.L., Cerundolo V. TAP deficiency syndrome. Clin. Exp. Immunol. 121:2000;173-178.
49. Yabe T., Kawamura S., Sato M., Kashiwase K., Tanaka H., Ishikawa Y., Asao Y., Oyama J., Tsuruta K., Tokunaga K., Tadokoro K., Juji T. A subject with a novel type I bare lymphocyte syndrome has tapasin deficiency due to deletion of 4 exons by Alu-mediated recombination. Blood. 100:2002;1496-1498.
50. de la Salle H., Saulquin X., Mansour I., Klayme S., Fricker D., Zimmer J., Cazenave J.P., Hanau D., Bonneville M., Houssaint E., Lefranc G., Naman R. Asymptomatic deficiency in the peptide transporter associated to antigen processing (TAP). Clin. Exp. Immunol. 128:2002;525-531.